Navigation Links
AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System
Date:11/4/2010

COLD SPRING HARBOR, N.Y., Nov. 4, 2010 /PRNewswire/ -- AccuVein LLC, the developer of the first non-contact, handheld vein illumination system, announced today that it had been awarded the maximum grant amount from the Qualifying Therapeutic Discover Project (QTDP) program.  This Federal grant program supports projects that show significant potential to produce new therapies, address unmet medical needs, and reduce the long-term growth of health care costs.

AccuVein's AV300 helps health care professionals locate veins for blood draw, IV infusion and blood donation by projecting a pattern of light on patient's skin that reveals the position of underlying veins.  This 10-ounce, hand-held device is available with a range of hands-free options so that it can quickly free the practitioner's hands to perform the venipuncture.  It is the first and only system of its kind.

"Hospitals are adopting vein visualization as the standard-of-care for venipuncture as a tool to reduce error, reduce cost and increase patient satisfaction," said AccuVein engineering vice president Joe Zott.  "Winning this grant will support our continued investment in delivering the best vein illumination system in the market."

About AccuVein

AccuVein LLC is a supplier of innovative, cutting-edge medical devices. The award winning AV300 allows health care providers to see a map of the position of peripheral veins on the skin's surface with the goal of helping to improve venipuncture procedures. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. The AccuVein AV300 was the recipient of the 2010 Medical Design Excellence Award and was cited as a 2009 best new product in Contemporary Pediatrics Magazine.   AccuVein has filed applications for more than a dozen patents on the AV300's technology. It is in use at more than 400 U.S. hospitals and available for sale in over 50 countries. For more information on AccuVein's AV300, please visit www.accuvein.com.


'/>"/>
SOURCE AccuVein
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
2. AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device
3. AccuVein AV300 Named a Best New Product by Contemporary Pediatrics
4. AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device
5. Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs
6. DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant
7. Cardiogenesis Receives Research Award From Federal Government
8. BioMedixs TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification
9. Pfizers Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
10. Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test
11. BD Ranks Among Top 25 U.S. Companies in Newsweeks 2010 Green Rankings; Receives EPA Green Power Leadership Award; Named to Dow Jones Sustainability World Index for Fifth Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):